| Ticker Details |
|
Standard BioTools Inc.
|
| IPO Date: |
March 1, 2011 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$355.39M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.06 | 3.46%
|
| Avg Daily Range (30 D): |
$0.02 | 1.92%
|
| Avg Daily Range (90 D): |
$0.03 | 2.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
1.93M |
| Avg Daily Volume (90 D): |
1.49M |
| Trade Size |
| Avg Trade Size (Sh.): |
192 |
| Avg Trade Size (Sh.) (30 D): |
221 |
| Avg Trade Size (Sh.) (90 D): |
219 |
| Institutional Trades |
| Total Institutional Trades: |
131 |
| Avg Institutional Trade: |
$1.82M |
| Avg Institutional Trade (30 D): |
$1.09M |
| Avg Institutional Trade (90 D): |
$1.02M |
| Avg Institutional Trade Volume: |
1M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.83M |
| Avg Closing Trade (30 D): |
$1.32M |
| Avg Closing Trade (90 D): |
$1.17M |
| Avg Closing Volume: |
1.54M |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.2
|
$.05
|
$-.2
|
|
Diluted EPS
|
$-.2
|
$.05
|
$-.2
|
|
Revenue
|
$85.33M
|
$23.8M
|
$85.33M
|
|
Gross Profit
|
$42.54M
|
$11.38M
|
$42.54M
|
|
Net Income / Loss
|
$-74.9M
|
$19.28M
|
$-74.9M
|
|
Operating Income / Loss
|
$-110.25M
|
$-24.64M
|
$-110.25M
|
|
Cost of Revenue
|
$42.79M
|
$12.41M
|
$42.79M
|
|
Net Cash Flow
|
$-45.52M
|
$-8.71M
|
$-45.52M
|
|
PE Ratio
|
|
|
|
|
|
|